FDA Oncology Announcements

Announcements Trials

Somatostatin analog × Endocrine × Clear all

Conditions

Drug Classes

RET inhibitor 8 VEGFR inhibitor 5 Anti-PD-1 4 Multikinase inhibitor 3 Radioactive agent 3 BRAF inhibitor 2 HIF-2a inhibitor 2 MEK inhibitor 2 MTOR inhibitor 2 TRK inhibitor 2 Anti-HER2 ADC 1 ROS1 inhibitor 1 Somatostatin analog 1

1 Announcement

Lanreotide

Drug: Somatuline Depot (lanreotide) · Somatostatin analog
Conditions: EndocrineNET

Data powered by HemOnc (CC BY 4.0) Colophon ⚡